Antigen-independent activation is critical for the durable antitumor effect of GUCY2C-targeted CAR-T cells
Background Chimeric antigen receptor (CAR)-T cells face many obstacles in solid tumor therapy, including heterogeneous antigen expression and inefficient T cell persistence. Guanylyl cyclase C (GUCY2C) has been identified as a suitable tumor antigen for targeted therapy due to its intestinal-restric...
Saved in:
| Main Authors: | Xiaofei Wei, Lin Shen, Chang Liu, Cheng Zhang, Min Tao, Jian Li, Xicheng Wang, Ting He, Fei Dai, Changsong Qi, Mingyang Ma, Yanping Ding, Xinan Lu, Dongqun Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/10/e009960.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy
by: Trevor R. Baybutt, et al.
Published: (2024-12-01) -
Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
by: Eric Bartee, et al.
Published: (2020-05-01) -
Tumor Antigen-Dependent and Tumor Antigen-Independent Activation of Antitumor Activity in T Cells by a Bispecific Antibody-Modified Tumor Vaccine
by: Philippe Fournier, et al.
Published: (2010-01-01) -
Expression and clinical significance of GUCY2C in colorectal cancer: implications for targeted therapy
by: Liu Lu, et al.
Published: (2025-02-01) -
Gucy1α1 specifically marks kidney, heart, lung and liver fibroblasts
by: Valeria Rudman-Melnick, et al.
Published: (2024-11-01)